Emergent BioSolutions

6.23
Open
6.20
Market Cap
319.95M+
High
6.25
Low
6.01
Close
6.23
Volume
727.33K+
P/E Ratio
6.71
Div/Yield
0.00%

About Emergent BioSolutions

Emergent BioSolutions Inc 向政府和醫療保健提供者提供公共衛生產品。 該公司經營三個不同的部門,即商業部門、產品部門和服務部門。 其主要收入來自商業部門,其中包括 NARCAN® 和其他商業產品。

如何購買 Emergent BioSolutions (EBS)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 EBS

購買 EBS

透過 RockFlow App 或網頁端搜尋 EBS,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

社交媒體

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.